Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase
- 1 January 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 1 (1) , 45-48
- https://doi.org/10.1093/mutage/1.1.45
Abstract
Rat small intestinal microsomes have been compared with liver preparations for the ability to activate promutagens using the Salmonella mutagenicity assay. Induced levels of arylhydrocarbon hydroxylase and cytochrome P-450 in intestinal microsomes are significantly lower than the corresponding amounts in liver microsomes. Greater activation of benzo[a]pyrene (BP) by liver extracts would thus be expected. Although this was observed at > 1 .mu.g BP/plate, at lower doses comparatively high levels of activation were obtained with intestinal microsomes. This could be due to preferential formation of the mutagenic 4,5-oxide with intestinal microsomes, as opposed to the putative major active metabolite, the 7,8-diol-9,10-epoxide. Microsomal epoxide hydrolase inactivates the K-region epoxide by forming the corresponding dihydro-diol. Differences in the levels of these metabolites may thus be a result of higher activity of the enzyme in liver extracts. This hypothesis has been studied using the epoxide hydrolase inhibitor, 1,2-epoxy-3,3,3,-trichloropropylene oxide (TCPO). Enzyme activity has been measured using [3H]-BP-4,5-oxide as substrate. Since aflatoxin B1 (AFB) may also be activated via analogous epoxide intermediates, the effects of TCPO on activation of AFB were also investigated. Intestinal microsomal expoxide hydrolase activities were significantly lower than those in liver preparations obtained from animals pre-treated with enzyme inducers. Enzyme activity and promutagen activation ability of intestinal microsomes, respectively, were less susceptible to and not inhibited by TCPO. However, TCPO strongly inhibited microsomal epoxide hydrolase activity and activation of BP and AFB due to liver microsomes. The differences in dose-responses for mutagenicity of BP and AFB obtained are discussed with respect to the relative involvement of epoxide hydrolase in the activation of the two promutagens by the different microsomal preparations used.This publication has 9 references indexed in Scilit:
- Characterization of a microsomal fraction from rat small intestine for metabolic activation of some promutagensCarcinogenesis: Integrative Cancer Research, 1985
- Intramucosal carcinoma of the small intestine arising in regional enteritis (Crohn's Disease). Report of a case studied for carcinoembryonic antigen and review of the literatureCancer, 1984
- Evaluation of a methodology for the use of preparations from rat small intestine in the Salmonella/microsome assayMutation Research/Environmental Mutagenesis and Related Subjects, 1983
- The aza-arenes as mutagens for Salmonella typhimuriumMutation Research/Genetic Toxicology, 1982
- Continuous fluorometric assay of epoxide hydrase activityAnalytical Biochemistry, 1979
- Specificity of human, rat and mouse skin epoxide hydratase towards K-region epoxides of polycyclic hydrocarbonsBiochemical Pharmacology, 1978
- The apparent ubiquity of epoxide hydratase in rat organsBiochemical Pharmacology, 1977
- A rapid assay for epoxide hydratase activity with benzo(a)pyrene 4,5-(K-region-)oxide as substrateAnalytical Biochemistry, 1976
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951